 |
 Video: What is a Stock Split?
|
|
|
| Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea ("OSA"). Co.'s solution, Genio system, is a hypoglossal neurostimulation therapy for OSA. The Genio® system is a neurostimulator implant and is capable of delivering bilateral hypoglossal nerve stimulation to keep the upper airway open. The product is intended to be used as a second-line therapy to treat moderate to severe OSA patients who have failed conventional therapy. According to our Nyxoah SA stock split history records, Nyxoah SA has had 0 splits. | |
|
Nyxoah SA (NYXH) has 0 splits in our Nyxoah SA stock split history database.
Looking at the Nyxoah SA stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Nyxoah SA shares, starting with a $10,000 purchase of NYXH, presented on a split-history-adjusted basis factoring in the complete Nyxoah SA stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/29/2021 |
|
| End date: |
05/02/2024 |
|
| Start price/share: |
$24.00 |
|
| End price/share: |
$9.93 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-58.62% |
|
| Average Annual Total Return: |
-25.40% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,138.30 |
|
| Years: |
3.01 |
|
|
|
|
|
